Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yong Seok Chang
Treatment-Shortening Effect of a Novel Regimen Combining High-Dose Rifapentine and Clofazimine in Pathologically Distinct Mouse Models of Tuberculosis
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Daily Rifapentine for Treatment of Pulmonary Tuberculosis. A Randomized, Dose-Ranging Trial
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
Shorter-Course Treatment for Mycobacterium Ulcerans Disease With High-Dose Rifamycins and Clofazimine in a Mouse Model of Buruli Ulcer
PLoS Neglected Tropical Diseases
Pharmacology
Public Health
Environmental
Toxicology
Infectious Diseases
Pharmaceutics
Occupational Health
Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Limited Activity of Clofazimine as a Single Drug in a Mouse Model of Tuberculosis Exhibiting Caseous Necrotic Granulomas
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Rapid VAC High Dose Melphalan Regimen, a Novel Chemotherapy Approach in Childhood Soft Tissue Sarcomas
British Journal of Cancer
Cancer Research
Oncology
Evaluation of Rifalazil in a Combination Treatment Regimen as an Alternative to Isoniazid-Rifampin Therapy in a Mouse Tuberculosis Model
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Short-Course Chemotherapy With TMC207 and Rifapentine in a Murine Model of Latent Tuberculosis Infection
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
Gastrointestinal Safety of Aspirin for a High-Dose, Multiple-Day Treatment Regimen: A Meta-Analysis of Three Randomized Controlled Trials
Drugs in R and D
Pharmacology
